Home Immunology & Inflammation -GPCR & G Protein LTR

LTR

Isoform-selective Products

LTR Products

  • All (9)
  • LTR Inhibitor (1)
  • LTR Antagonists (8)
  • New LTR Products
Catalog No. Product Name Information Product Use Citations Product Validations
S8126 MK571 MK571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.
Cancers (Basel), 2023, 15(15)3774
DSpace, 2023, 10.33540/2012
Pharmaceutics, 2022, 14(9)1948
S4211 Montelukast Sodium Montelukast Sodium selectively antagonizes leukotriene D4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. Montelukast improves macroautophagy but not the chaperone-mediated autophagy pathway. Solutions are unstable and should be fresh-prepared.
Biochem Biophys Res Commun, 2022, 594:31-37
Cancer Immunol Immunother, 2021, 70(1):203-213
Aging (Albany NY), 2021, 13(24):25670-25693
S1633 Zafirlukast Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.
Sci Rep, 2023, 13(1):13239
Sci Rep, 2023, 13(1):13239
Traffic, 2023, 24(4):177-189
S5783 Montelukast Montelukast(MK0476) is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
Biochem Biophys Res Commun, 2022, 594:31-37
Cancer Immunol Immunother, 2021, 70(1):203-213
Aging (Albany NY), 2021, 13(24):25670-25693
S0505 MK-571 sodium salt MK-571 sodium salt (L-660711) is a selective, orally active antagonist of leukotriene D4 receptor. It is also an inhibitor of multidrug resistance-associated protein MRP4 (ABCC4) and ABCC1 (MRP1).
Diagnostics -Basel), 2023, 13(16)2646
Diagnostics (Basel), 2023, 13(16)2646
Cancers (Basel), 2022, 14(11)2643
S3998 (+)-α-Lipoic acid (+)-α-Lipoic acid ((R)-(+)-α-Lipoic acid, α-Lipoic acid, Alpha-Lipoic acid), a physiological form of thioctic acid, is a strong antioxidant that relieves diabetic neuropathic symptoms. It shows superior antioxidative effects to its racemate. R(+)-α-lipoic acid is an essential cofactor of mitochondrial enzyme complexes. R(+)-α-lipoic acid inhibits NF-κB-dependent HIV-1 LTR activation.
J Clin Invest, 2024, 134(22)e181314
E2671 SR 2640 hydrochloride SR2640 hydrochloride is a potent and selective competitive leukotriene D4/E4 antagonist.
S0428 Etalocib Etalocib(LY293111, VML295) is a leukotriene B4 receptor (LTB4R) antagonist that blocks activation of human neutrophils.
S2959 LY255283 LY255283 is an antagonist of leukotriene B4 (LTB4) receptor (BLT2) that displaces [3H]LTB4 from its binding site on lung membranes with pKi of 7.0.
J Transl Med, 2023, 21(1):923
S3998 (+)-α-Lipoic acid (+)-α-Lipoic acid ((R)-(+)-α-Lipoic acid, α-Lipoic acid, Alpha-Lipoic acid), a physiological form of thioctic acid, is a strong antioxidant that relieves diabetic neuropathic symptoms. It shows superior antioxidative effects to its racemate. R(+)-α-lipoic acid is an essential cofactor of mitochondrial enzyme complexes. R(+)-α-lipoic acid inhibits NF-κB-dependent HIV-1 LTR activation.
J Clin Invest, 2024, 134(22)e181314
S8126 MK571 MK571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.
Cancers (Basel), 2023, 15(15)3774
DSpace, 2023, 10.33540/2012
Pharmaceutics, 2022, 14(9)1948
S4211 Montelukast Sodium Montelukast Sodium selectively antagonizes leukotriene D4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1. Montelukast improves macroautophagy but not the chaperone-mediated autophagy pathway. Solutions are unstable and should be fresh-prepared.
Biochem Biophys Res Commun, 2022, 594:31-37
Cancer Immunol Immunother, 2021, 70(1):203-213
Aging (Albany NY), 2021, 13(24):25670-25693
S1633 Zafirlukast Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.
Sci Rep, 2023, 13(1):13239
Sci Rep, 2023, 13(1):13239
Traffic, 2023, 24(4):177-189
S5783 Montelukast Montelukast(MK0476) is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
Biochem Biophys Res Commun, 2022, 594:31-37
Cancer Immunol Immunother, 2021, 70(1):203-213
Aging (Albany NY), 2021, 13(24):25670-25693
S0505 MK-571 sodium salt MK-571 sodium salt (L-660711) is a selective, orally active antagonist of leukotriene D4 receptor. It is also an inhibitor of multidrug resistance-associated protein MRP4 (ABCC4) and ABCC1 (MRP1).
Diagnostics -Basel), 2023, 13(16)2646
Diagnostics (Basel), 2023, 13(16)2646
Cancers (Basel), 2022, 14(11)2643
E2671 SR 2640 hydrochloride SR2640 hydrochloride is a potent and selective competitive leukotriene D4/E4 antagonist.
S0428 Etalocib Etalocib(LY293111, VML295) is a leukotriene B4 receptor (LTB4R) antagonist that blocks activation of human neutrophils.
S2959 LY255283 LY255283 is an antagonist of leukotriene B4 (LTB4) receptor (BLT2) that displaces [3H]LTB4 from its binding site on lung membranes with pKi of 7.0.
J Transl Med, 2023, 21(1):923

Choose Selective LTR Inhibitors

Tags: LTR inhibitor|LTR agonist|LTR activator|LTR inducer|LTR antagonist|LTR signaling pathway|LTR assay kit